Navigation Links
SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
Date:9/22/2011

GERMANTOWN, Md., Sept. 22, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, today announced that Neil J. Campbell, president and CEO, will be presenting at AdvaMed 2011: The Medtech Conference in Washington, D.C. on September 27, 2011 at 11:00 a.m. in room 204A of the Walter E. Washington Convention Center in Washington, D.C.  

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology targeting four industry sectors: human health, animal health, industrial and biodefense/biosecurity.

"AdvaMed 2011 is the premier event for investors and leaders in the medical technology industry, and thus is an ideal opportunity for SuperNova to showcase its game-changing, disruptive technology and 'lab-in-the-palm-of-your-hand' diagnostic system," said Mr. Campbell.  "With our proprietary AmpCrystal® platform, which provides an array of diagnostic capabilities from patient treatment to pathogen detection, SuperNova has the potential to seize the still largely untapped multi-billion dollar point-of-care and point-of-use diagnostic market."

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / Madeleine Desmond
(212) 827-0020
jrando@tiberend.com / mdesmond@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics(R), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
2. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
3. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
4. InterMune to Present at Canaccord Adams Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
8. Bionovo to Present at Canaccord Adams Global Growth Conference
9. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
10. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
11. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
Breaking Biology News(10 mins):